Member Info for Dave77

Rejected

That was my thoughts, put in a fill or kill at 124, did this last week on higher amounts of £ and share price, kept on bouncing back and the share price went up each time I asked. Gave up and got some later.

Price drops each day this week, all these sellers, but cant buy any on HL? Top up time, if allowed, tried £28k, £18k, £8k, now £5k, NT. Tried £300 for a joke, still cant buy

Added the 2 other trades at 10.02 and the one at 9.59, 3 in total, whats that another 660,000 only to be diluted at 12.30,mmmmm. Hope these extra funds are for the app.

900,000 at average of 3p

A buy out for me would be my best ever day, an offer of anything above £3.40 would be amazing, £8 wow, id have a heart attack. Never had a bagger, £8 would nearly be 5 x.

Can only dream of such things!

Big B, I hope you are right. Makes you think they have a large sell order around 150 to complete. It was myself that bought the app £70k worth. Bring on the sales figures. Down app 10% at the mo.

Guys, the £38k at 151, and 4 of the recent trades around 151.25 in the last 30 mins are all buys. Not sure why the price is not going up and why these are being posted on LSE as sales.

News is en route?

Uk announces that new labs/testing have came on stream. The 200,000 testing capacity per day starting for June 01 can be met. Hope that involves GDR, and RNS first thing tomorrow.

Check out sharesmagazine, says share price opening at 25p, never noticed this before today, came across it by accident while researching. I hope it’s wrong.

No, John, seen it mentioned but cant find a date, be nice if you could advise?

Ive missed this, where is the mention of it and when is it?

First ever post. Been in this since before Sam-gate, tried to increase by £3000, NT on HL for 5-10 mins, but could sell £75,000 for 93p. Some one big must be accumulating . Hopefully a US buyer. Obv invested, holding and FYI no of shares over 5 accounts is 479,955 and still buying. Waiting on news from IL6 from other studies , patent , FDA on Covid approval for trials. Along with institutions other last weeks news.